Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03716960 · ClinicalTrials.gov registry record · NA

The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.

A NA study of Hypertension and Elevated Blood Pressure, sponsored by Marymount University.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT03716960 is a NA study of Hypertension and Elevated Blood Pressure that has completed, run by Marymount University. The registered enrollment target is 23 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03716960, a NA study of Hypertension and Elevated Blood Pressure, has completed, sponsored by Marymount University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Postmenopausal women have a higher prevalence of cardiovascular (CV) disease than age-match men. Growing evidence from rat studies have demonstrated CV-protective effects of pumpkin seed oil (PSO). The investigators hypothesis is that PSO would improve CV health in postmenopausal women.

Interventions

  • OTHER Placebo
  • OTHER Pumpkin Seed Oil

Study Locations (1)

Virginia

  • Marymount University - Arlington

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2017-09-01
Est. Completion 2018-06-30
Phase NA

Sponsor

Marymount University

6 total trials

What the Registry Record Tells You About NCT03716960

The ClinicalTrials.gov registry entry for NCT03716960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Marymount University, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03716960 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03716960 about?

NCT03716960 is a clinical study titled "The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.". Postmenopausal women have a higher prevalence of cardiovascular (CV) disease than age-match men. Growing evidence from rat studies have demonstrated CV-protective effects of pumpkin seed oil (PSO). The investigators hypothesis is that PSO would improve CV health in postmenopausal women.

What is the current status of trial NCT03716960?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-09-01. Estimated completion is 2018-06-30.

What conditions does trial NCT03716960 study?

This clinical trial studies the following conditions: Hypertension, Elevated Blood Pressure.

What interventions are being tested in trial NCT03716960?

The interventions under investigation include: Placebo (OTHER), Pumpkin Seed Oil (OTHER).

Who is sponsoring clinical trial NCT03716960?

This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03716960 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.